US Stock MarketDetailed Quotes

CASI CASI Pharmaceuticals

Watchlist
  • 6.0000
  • -0.3500-5.51%
Close Jul 22 16:00 ET
  • 5.8500
  • -0.1500-2.50%
Post 16:01 ET
80.41MMarket Cap-2631P/E (TTM)

CASI Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CASI Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 20, 2024

Revenue(YoY)

3.41M

-59.16%
EPS(YoY)

-0.71

-57.78%
Analyst Rating

Buy

May 15, 2024

CASI Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Nov 14, 20242024/Q3-- / 4.560M--
Aug 20, 20242024/Q2-- / 4.431M--
May 20, 20242024/Q13.409M / 12.000M--
Apr 1, 20242023/Q46.874M / 9.412M--
Nov 1, 20232023/Q38.838M / 10.428M--
DatePeriodRevenue/EstimateEarnings Call
Nov 14, 20242024/Q3-- / 4.560M--
Aug 20, 20242024/Q2-- / 4.431M--
May 20, 20242024/Q13.409M / 12.000M--
Apr 1, 20242023/Q46.874M / 9.412M--
Nov 1, 20232023/Q38.838M / 10.428M--

Unlock Free Earnings Estimates

CASI Pharmaceuticals Earnings Reports

  • CASI Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    May 15 06:55 ET

  • CASI Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 28 16:07 ET

  • CASI Pharmaceuticals | 20-F: Registration statement / Annual report / Transition report

    Mar 28 11:09 ET

  • CASI Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 14, 2023 16:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 15, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg